Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution-Reference-Cited by-同舟云学术

Allogeneic hematopoietic SCT in multiple myeloma: long-term results from a single institution

Published:2015-01-26 Issue:5 Volume:50 Page:658-662
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Rosiñol L,Jiménez R,Rovira M,Martínez C,Fernández-Avilés F,Marín P,Suárez-Lledó M,Gutiérrez-García G,Fernández de Larrea C,Carreras E,Urbano-Ispizua A,Bladé J

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2014320.pdf

Reference30 articles.

1. Ludwig H, Bolejack V, Crowley J, Bladé J, San Miguel J, Kyle RA et al. Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol 2010; 28: 1599–05.

2. Corradini P, Voena C, Tarella C, Astolfi M, Ladetto M, Palumbo A et al. Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol 1999; 17: 208–215.

3. Corradini P, Cavo M, Lokhorst H, Martinelli G, Terragna C, Majolino I et al. Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma. Blood 2003; 102: 1927–1929.

4. Gahrton G, Tura S, Ljungman P, Bladé J, Brandt L, Cavo M et al. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 1995; 13: 1312–1322.

5. Bensinger WI, Bucker CD, Anasetti C, Clift R, Storb R, Barnett T et al. Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on oucome. Blood 1996; 88: 2787–2793.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy;Cancers;2021-09-26

2. Expert review on soft‐tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations;British Journal of Haematology;2021-03-16

3. Allogeneic hematopoietic cell transplantation for multiple myeloma: A retrospective analysis of the Polish Myeloma Group;Advances in Medical Sciences;2020-09

4. LDH and renal function are prognostic factors for long-term outcomes of multiple myeloma patients undergoing allogeneic hematopoietic stem cell transplantation;Bone Marrow Transplantation;2020-02-17

5. Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017;Cancer Cell International;2018-04-23